A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).
Michael A, Wilson W, Sunshine S, Annels N, Harrop R, Blount D, Pandha H, Lord R, Ngai Y, Nicum S, Stylianou L, Gwyther S, McNeish IA, Hackshaw A, Ledermann J.
Michael A, et al.
Int J Gynecol Cancer. 2024 May 17:ijgc-2023-005200. doi: 10.1136/ijgc-2023-005200. Online ahead of print.
Int J Gynecol Cancer. 2024.
PMID: 38760075